Evidence map›Paper›PMID 20385253›Full record

ReviewAgeing research reviews2011

TOR signaling never gets old: aging, longevity and TORC1 activity.

Daniel S Evans, Pankaj Kapahi, Wen-Chi Hsueh, Lutz Kockel

Abstract readReview
In one paragraph

Review in Ageing research reviews, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Comparative transcriptomic analysis of the mechanisms underpinning ageing and fecundity in social insects.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2021
    Article
  11. Article
  12. Review
  13. Article
  14. Evolution, Chance, and Aging.Frontiers in genetics · 2021
    Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Daniel S EvansDepartment of Medicine, University of California, San Francisco, United States.
Pankaj Kapahi
Wen-Chi Hsueh
Lutz Kockel

Funding

Systems BiologyU19AG023122 · NIA · TRANSLATIONAL GENOMICS RESEARCH INST · PI Thomas Girke, NICHOLAS Joseph SCHORK · 2004 to 2026
$102.6M
DIABETES, ENDOCRINOLOGY &METABOLISM TRAINING PROGRAMT32DK007418 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI EDWARD C HSIAO · 1986 to 2026
$14.3M
Genetic Epidemiology of Telomere Length in the AmishR01AG023692 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HSUEH, WEN-CHI · 2004 to 2008
$1.5M
Diurnal Preference in Amish FamiliesK01AG022782 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HSUEH, WEN-CHI · 2003 to 2007
$730k
NIA NIH HHS 5 U19 AG023122NIA NIH HHS K01 AG022782NIA NIH HHS R01 AG023692NIA NIH HHS U19 AG023122NIDDK NIH HHS T32 DK007418
6 · The paper itself

Abstract

The target of rapamycin (TOR) signal transduction network monitors intra- and extracellular conditions that favor cell growth. Research during the last decade has revealed a modular structure of the TOR signaling network. Each signaling module senses a particular set of signals from the cellular milieu and exerts regulatory control towards TOR activity. The TOR pathway responds to growth factor signals, nutrient availability, and cellular stresses like hypoxia and energy stress. The signaling modules and their molecular components constituting the TOR network are remarkably conserved in both sequence and function across species. In yeast, roundworms, flies, and mice, the TOR pathway has been shown to regulate lifespan. Correspondingly, genetic, dietary or pharmacological manipulation of individual signaling modules as well as TOR activity itself extends lifespan in these model organisms. We discuss the potential impact of manipulating TOR activity for human health and lifespan.

Indexed as

Gene Expression RegulationAgingAnimalsHumansLongevityMiceProtein Serine-Threonine KinasesRibosomal Protein S6 KinasesSaccharomyces cerevisiae ProteinsSignal TransductionTranscription FactorsCRTC1 protein, humanProtein Serine-Threonine KinasesRibosomal Protein S6 KinasesSaccharomyces cerevisiae Proteinstarget of rapamycin protein, S cerevisiaeTranscription Factors

Identifiers

PMID20385253
PMCPMC2943975

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.